Background and Purpose—Thrombosis of cerebral veins and sinus (cerebral venous
thrombosis) is a rare stroke pathogenesis. Pharmaceutical treatment is restricted to heparin …

Background Venous thrombosis affecting cerebral veins and sinuses (CVT) is an uncommon
neurological condition. Traditionally patients are treated with intravenous heparin followed …

Abstract Background New Oral Anticoagulants (NOACs) such as Rivaroxaban are
introduced as alternatives to conventional vitamin-K antagonists in the long-term treatment …

Background The effect of different anticoagulants on recanalization after cerebral venous
thrombosis has not been studied in a randomized controlled trial. Methods RE-SPECT CVT …

Background: Cerebral venous thrombosis (CVT) is an uncommon neurological condition
usually treated with heparin followed by oral vitamin K antagonists (VKAs). In patients with …

Background: Cerebral venous thrombosis (CVT) is rare and involves thrombosis of the veins
and sinuses of the brain, most commonly the superior sagittal sinus. Approximately 5 CVT …

Cerebral venous and sinus thrombosis is a still underdiagnosed cause of stroke, with an
incidence of about 2.8 events per 100,000 person-years in young women and about 1.3 …

Background Cerebral vein thrombosis is a rare cause of stroke with significant risk of death
and long-term dependency. Anticoagulation has been associated with better long-term …

Vitamin K antagonists (VKAs) are guideline-suggested subacute anticoagulants for cerebral
venous sinus thrombosis (CVST), although there is potential hemorrhage risk in clinical use …

Cerebral venous and sinus thrombosis (CVT) is a rare form of thrombosis, with many
different clinical manifestations. Better imaging techniques have greatly improved the …